Therefore, in addition to the effects of neurohormonal modulators such as beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, and aldosterone antagonists, SDB could be a potential therapeutic target for HF [4]. This evidence concerns the gene ACE and hydrops fetalis.